Alvogen Establishes New CRO In India
Alvogen said that the CRO will specialise in the management of clinical trials and offer a complete range of clinical research services to Alvogen and third parties. The
The European Commission (EC) has granted orphan designation to Lundbeck’s investigational monoclonal antibody asedebart (Lu AG13909) for the treatment of Cushing’s syndrome of endogenous origin.
SCHEMA ST4’s range of application covers such areas as technical documentation, software documentation and help systems, catalogs, labeling for pharmaceutical companies, loose-leaf publications for specialized publishers, contract management
Takeda has executed agreements with Mylan Pharmaceuticals (Mylan), Watson Pharmaceuticals (Watson), Ranbaxy Pharmaceuticals (Ranbaxy), Alphapharm (Alphapharm), Torrent Pharmaceuticals (Torrent) and Sandoz and their respective affiliates, to settle patent